Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression

Depression Clinical Trial

Official title:

Yoga, Health, and Meditation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00090506
• Other study ID #: R21AT001942-01
• Status: Completed
• Phase: Phase 1
• First received: August 26, 2004
• Last updated: January 23, 2008
• Start date: July 2004
• Est. completion date: March 2007

Study information

• Verified date: January 2008
• Source: National Center for Complementary and Integrative Health (NCCIH)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.

Description:

In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.

Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: March 2007
• Est. primary completion date: March 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 14 Years to 40 Years

Eligibility

Inclusion Criteria for Study 1 Participants:

• Meet certain laboratory requirements

Inclusion Criteria for Study 2 Participants:

• HIV infected

• Able to walk at least 50% of the time

Inclusion Criteria for All Participants:

• Written informed consent of parent/guardian, if applicable

Exclusion Criteria for Study 2 Participants:

• Require antiretroviral therapy

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Diabetes
• HIV Infections

Intervention

Behavioral:
• Yoga

Locations

Country	Name	City	State
India	Swami Vivekananda Yoga Anusandhana Samsthana (SVAYSA)	Bangalore

Sponsors (1)

Lead Sponsor	Collaborator
National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

India,